Approval · Notice of Compliance 9868 · 2008
ACZONE: Notice of Compliance 9868
Issued November 4, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9868
- Date
- November 4, 2008
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-acne therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACZONE | 02281074 | Marketed |
Medicinal ingredients
- DAPSONE 5 PER